GDF2 and pulmonary arterial hypertension: Mutations in BMP9 and its' receptors underlie vascular diseases, namely hereditary hemorrhagic telangiectasia (ALK1, endoglin, and BMP9) (29, –31) and pulmonary arterial hypertension (ALK1, BMPR2) (32, –34).